Your email has been successfully added to our mailing list.

×
0 0 0 0 0 0 0 0.0199148936170213
Stock impact report

Bioverativ: Advancing Hemophilia Treatments [Seeking Alpha]

BIOVERATIV INC COMMON (BIVV) 
Last bioverativ inc common earnings: 2/13 04:15 pm Check Earnings Report
Company Research Source: Seeking Alpha
Summary Bioverativ ( BIVV ) is a recent spin-off from Biogen Idec ( BIIB ), which focuses on rare blood diseases, primarily hemophilia. Their products ELOCTATE and ALPROLIX represent one of the most significant advances in hemophilia treatment over the past 20 years. The main advantage is a longer duration in the patient's bloodstream which decreases the number of hospital visits per week needed for treatment, decreasing the costs for the patient and the healthcare system in general. As a result, the company has been rapidly taking market share from incumbent players. The stock is currently undervalued and an investor buying now can purchase the hemophilia business for less than it's worth, plus he will get all potential gains from pipeline products for free. Business description Bioverativ is a global biotechnology company focused on the discovery, research, development and commercialization of therapies for the treatment of hemophilia and other blood disorders. It wa Show less Read more
Impact Snapshot
Event Time:
BIVV
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
Last price at news event
Since Event
Multi-day stock performance from the time of the news release
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST
PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
Last Price
VWAP
High:
Max Up
High:
Low:
Max Down
Low:
%
Post news range
%
Price change

Price Change Percentage


S&P 500
(SPX)

%

Volume ratio
%

Volume
Ticks

Avg transaction size

Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Opt-in for BIVV alerts
Opt-in for
BIVV alerts

from News Quantified
Opt-in for
BIVV alerts

from News Quantified